Endovascular stenting for aortic coarctation

Carlo B Pilla1, Valmir F Fontes, Carlos A C Pedra

  • 1Pediatric Cardiology and Catheterization Laboratory, Irmandade da Santa Casa de Misericórdia de Porto Alegre, 90035-074 Porto Alegre, RS, Brazil. cbpilla@hotmail.com

Insights

Coarctation stenting offers a promising, less invasive treatment for aortic coarctation, showing encouraging early results with low restenosis and complication rates compared to surgery or balloon angioplasty.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Coarctation of the aorta is a common congenital heart defect.
  • Surgery is the traditional treatment, but less invasive options are sought.
  • Balloon angioplasty has limitations including restenosis and aneurysm formation.

Purpose of the Study:

  • To review current evidence on endovascular stenting for native coarctation of the aorta.
  • To discuss the efficacy and safety of coarctation stenting.
  • To explore future trends in aortic coarctation management.

Main Methods:

  • Review of existing literature on coarctation stenting.
  • Analysis of early- and intermediate-term outcomes.
  • Comparison of stenting with surgical and balloon angioplasty treatments.

Main Results:

  • Endovascular stenting shows encouraging early- and intermediate-term results.
  • Stenting is associated with low rates of restenosis.
  • Complication rates for stenting appear favorable.

Conclusions:

  • Coarctation stenting is an effective alternative to surgery and balloon angioplasty.
  • Stenting offers a less invasive approach with favorable outcomes.
  • Further research and development in coarctation stenting are warranted.